関連文献

Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass.

J Am Coll Cardiol. 58(22): 2301-2309, 2011.PubMed

Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity.

Am J Pathol. 178(3): 1021-1032, 2011.PubMed

Clinical significance of tubular and podocyte biomarkers in acute kidney injury.

Clin Exp Nephrol. 15(2): 220-225, 2011.PubMed

Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit.

Crit Care Med. 39(11): 2464-2469, 2011.PubMed

Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury.

Crit Care Med. 38(10): 2037-2042, 2010PubMed

Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage.

Am J Pathol. 174(6): 2096-2106, 2009.PubMed

Urinary L-type fatty acid-binding protein can reflect renal tubulointerstitial injury.

Am J Pathol. 174(4): 1203-1211, 2009.PubMed

Monitoring of urinary L-type fatty acid-binding protein predicts histological severity of acute kidney injury.

Am J Pathol. 174(4): 1154-1159, 2009.PubMed

Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion.

Shock. 31(5): 454-459, 2009.PubMed

Urinary human L-FABP is a potential biomarker to predict COX-inhibitor-induced renal injury.

Nephron Exp Nephrol. 108(1): e19-26, 2008.PubMed